Clostridioides difficile: Reduced Susceptibility to Vancomycin?

The article focuses on a study examining the impact of reduced vancomycin susceptibility in Clostridioides difficile and its association with clinical outcomes in patients treated with vancomycin. Topics include the relationship between vancomycin susceptibility and clinical response, the role of ribotype 027 in treatment failure, and potential strategies for managing patients with reduced vancomycin susceptibility.